IL6 and Parkinson disease: In contrast, a recent study has shown that TRPV1 modulates M1/M2 macrophage polarization and decreases the levels of M1 macrophage markers, inducible nitric oxide synthase (iNOS) and interleukin-6 (IL-6), to promote dopaminergic neurons survival in a Parkinson’s disease model18.